{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:46:37Z","timestamp":1791398797016,"version":"4.3.3"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijcard.2020.09.020","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:26:34Z","timestamp":1599737194000},"page":"235-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Economic consequences of rheumatic heart disease: A scoping review"],"prefix":"10.1016","volume":"323","author":[{"given":"Chinonso C.","family":"Opara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negeen","family":"Aghassibake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijcard.2020.09.020_bb0005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and National Burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2020.09.020_bb0010","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.socscimed.2005.07.001","article-title":"What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?","volume":"62","author":"McIntyre","year":"2006","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.ijcard.2020.09.020_bb0015","series-title":"Cardiovascular, Respiratory, and Related Disorders","article-title":"Structural heart diseases","author":"Watkins","year":"2017"},{"issue":"48","key":"10.1016\/j.ijcard.2020.09.020_bb0020","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1093\/eurheartj\/ehy764","article-title":"WHO Resolution on rheumatic heart disease","volume":"39","author":"White","year":"2018","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1016\/j.ijcard.2020.09.020_bb0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation the PRISMA-ScR statement","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2020.09.020_bb0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1715163518790993","article-title":"Cost-minimization analysis of community pharmacy-based point-of-care testing for strep throat in 5 Canadian provinces","volume":"151","author":"Lathia","year":"2018","journal-title":"Can. Pharm. J."},{"issue":"3","key":"10.1016\/j.ijcard.2020.09.020_bb0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCOUTCOMES.111.000032","article-title":"Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis","volume":"6","author":"Irlam","year":"2013","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"964","key":"10.1016\/j.ijcard.2020.09.020_bb0040","first-page":"400","article-title":"Analysis of costs of acute rheumatic fever and rheumatic heart disease in Auckland","volume":"106","author":"North","year":"1993","journal-title":"N. Z. Med. J."},{"issue":"8","key":"10.1016\/j.ijcard.2020.09.020_bb0045","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1440-1754.2012.02446.x","article-title":"Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand","volume":"48","author":"Milne","year":"2012","journal-title":"J. Paediatr. Child Health"},{"issue":"1","key":"10.1016\/j.ijcard.2020.09.020_bb0050","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1186\/s12889-015-2538-z","article-title":"Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review","volume":"15","author":"Brouwer","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijcard.2020.09.020_bb0055","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"issue":"46","key":"10.1016\/j.ijcard.2020.09.020_bb0065","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1016\/j.vaccine.2018.10.001","article-title":"An economic case for a vaccine to prevent group A streptococcus skin infections","volume":"36","author":"Cannon","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijcard.2020.09.020_bb0070","series-title":"The Economic Impact of Rheumatic Heart Disease (RHD) on the Health System of South Africa. A Cost of Illness Study","author":"Hellebo","year":"2018"},{"key":"10.1016\/j.ijcard.2020.09.020_bb0075","series-title":"The Household Economic Impact of Rheumatic Heart Disease (RHD) in South Africa","author":"Oyebamiji","year":"2018"},{"issue":"2","key":"10.1016\/j.ijcard.2020.09.020_bb0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-0484","article-title":"Burden and economic cost of group a streptococcal pharyngitis","volume":"121","author":"Pfoh","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ijcard.2020.09.020_bb0085","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00296-012-2554-6","article-title":"The economic burden of rheumatic heart disease in South Korea","volume":"33","author":"Seo","year":"2013","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.ijcard.2020.09.020_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1478-4505-11-31","article-title":"The financial burden from non-communicable diseases in low- and middle-income countries: a literature review","volume":"11","author":"Kankeu","year":"2013","journal-title":"Health Res. Policy Syst."},{"key":"10.1016\/j.ijcard.2020.09.020_bb0095","series-title":"Universal Health Coverage and Essential Packages of Care","author":"Watkins","year":"2017"},{"issue":"6","key":"10.1016\/j.ijcard.2020.09.020_bb0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/tmi.13235","article-title":"Echocardiographic screening of 4107 Nigerian school children for rheumatic heart disease","volume":"24","author":"Ekure","year":"2019","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.ijcard.2020.09.020_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2261-12-23","article-title":"The burden of antenatal heart disease in South Africa: a systematic review","volume":"12","author":"Watkins","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"issue":"2","key":"10.1016\/j.ijcard.2020.09.020_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7326\/0003-4819-139-2-200307150-00011","article-title":"Diagnosis and management of adults with pharyngitis: a cost-effectiveness analysis","volume":"139","author":"Neuner","year":"2003","journal-title":"Ann. Intern. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320338018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320338018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:51:03Z","timestamp":1759092663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320338018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":21,"alternative-id":["S0167527320338018"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.09.020","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic consequences of rheumatic heart disease: A scoping review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}